← Back to Search

Benzodiazepine

Midazolam Sedation for Endoscopy

Phase < 1
Waitlist Available
Research Sponsored by Greg S Cohen MD LLC
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, an average of 1 year
Awards & highlights
All Individual Drugs Already Approved
Approved for 5 Other Conditions
No Placebo-Only Group

Summary

This trial is designed to see if midazolam alone is as effective and safe as a combination of midazolam and fentanyl for GI endoscopy.

Eligible Conditions
  • Anesthesia
  • Endoscopy
  • Colonoscopy
  • Conscious Sedation

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, an average of 1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, an average of 1 year for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Adequacy of Sedation
Pain Felt During the Procedure
Secondary study objectives
Adenoma Detection Rate
Adverse Events
Cecal Intubation Rate
+3 more

Awards & Highlights

All Individual Drugs Already Approved
Therapies where all constituent drugs have already been approved are likely to have better-understood side effect profiles.
Approved for 5 Other Conditions
This treatment demonstrated efficacy for 5 other conditions.
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: midazolam aloneExperimental Treatment1 Intervention
Patients in this arm will receive conscious sedation with medazepam alone
Group II: midazolam and fentanylActive Control1 Intervention
Patients in this arm will receive standard conscious sedation with midazolam and fentanyl
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Midazolam
FDA approved

Find a Location

Who is running the clinical trial?

Greg S Cohen MD LLCLead Sponsor

Media Library

Midazolam (Benzodiazepine) Clinical Trial Eligibility Overview. Trial Name: NCT04807101 — Phase < 1
Anesthesia Research Study Groups: midazolam and fentanyl, midazolam alone
Anesthesia Clinical Trial 2023: Midazolam Highlights & Side Effects. Trial Name: NCT04807101 — Phase < 1
Midazolam (Benzodiazepine) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04807101 — Phase < 1
~64 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top